Edition:
United States

Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

7.82USD
10:07am EST
Change (% chg)

$0.12 (+1.56%)
Prev Close
$7.70
Open
$7.75
Day's High
$7.83
Day's Low
$7.75
Volume
1,357
Avg. Vol
49,935
52-wk High
$10.24
52-wk Low
$2.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.47 -0.919
Jun '17 0.25 -1.154
Mar '17 0.13 -0.683
FY 2016 Dec '16 0.13 -0.676
Sep '16 0.16 -0.683
Jun '16 0.00 -0.754
Mar '16 0.00 -0.760
FY 2015 Dec '15 0.00 -0.652
Sep '15 0.00 -0.823
Jun '15 0.18 -0.858
Mar '15 0.00 -0.791
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.80 2.00 0.00 0.00
Quarter Ending Mar-18 1 2.00 2.00 2.00 --
Year Ending Dec-17 3 1.66 2.90 0.86 0.12
Year Ending Dec-18 4 5.62 10.00 0.00 0.83
Earnings (per share)
Quarter Ending Dec-17 4 -0.65 -0.28 -0.80 -0.50
Quarter Ending Mar-18 2 -0.81 -0.75 -0.87 --
Year Ending Dec-17 4 -2.93 -2.88 -3.03 -2.79
Year Ending Dec-18 4 -3.11 -2.59 -3.75 -2.63
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.97 35.27
P/E High - Last 5 Yrs. -- 274.53 45.26
P/E Low - Last 5 Yrs. -- 92.51 24.18
Beta 2.87 0.83 0.91
Price to Sales (TTM) 161.83 114.29 5.83
Price to Book (MRQ) -- 22.17 5.62
Price to Tangible Book (MRQ) 2.22 25.97 7.22
Price to Cash Flow (TTM) -- 101.40 24.19
% Owned Institutions 71.33 5.64 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.04
Dividend 5 Year Growth Rate -- 1.96 5.26
Payout Ratio(TTM) -- 96.00 46.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 192.59 -3.18 6.84
Sales (TTM) vs TTM 1 Yr. Ago 512.35 30.07 5.66
Sales - 5 Yr. Growth Rate -48.20 33.24 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -34.47 -149.23 7.22
EPS (TTM) vs TTM 1 Yr. Ago -20.44 -- --
EPS - 5 Yr. Growth Rate -- 43.30 10.92
Capital Spending - 5 Yr. Growth Rate -2.17 40.86 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 7.59 5.74 3.56
LT Debt to Equity (MRQ) 0.00 14.43 13.40
Total Debt to Equity (MRQ) 0.00 16.88 19.46
Interest Coverage (TTM) -- -147.14 44.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.80 54.92
Gross Margin - 5 Yr. Avg. -- 55.48 52.46
EBITD Margin (TTM) -5,857.86 -- --
EBITD - 5 Yr. Avg -2,548.91 -218.62 15.49
Operating Margin (TTM) -5,936.90 -632.11 6.65
Operating Margin - 5 Yr. Avg. -2,601.61 -235.48 10.97
Pre-Tax Margin (TTM) -5,895.26 -603.10 7.47
Pre-Tax Margin - 5 Yr. Avg. -2,654.52 -235.80 11.38
Net Profit Margin (TTM) -5,895.26 -600.62 3.70
Net Profit Margin - 5 Yr. Avg. -2,654.52 -239.05 7.67
Effective Tax Rate (TTM) -- 15.26 24.26
Effective Tax Rate - 5 Yr. Avg. -- 18.70 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 21,106 21,614,065 848,695,288
Net Income/Employee (TTM) -1,244,277 -1,754,114 99,009,570
Receivable Turnover (TTM) -- 25.64 6.11
Inventory Turnover (TTM) -- 2.61 3.55
Asset Turnover (TTM) 0.01 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -80.29 -9.38 11.28
Return on Assets - 5 Yr. Avg. -65.97 0.11 12.25
Return on Investment (TTM) -93.32 -11.84 14.40
Return on Investment - 5 Yr. Avg. -74.68 3.18 16.04
Return on Equity (TTM) -289.17 -36.93 15.99
Return on Equity - 5 Yr. Avg. -403.08 5.57 17.25
  1 Year 3 Year 5 Year
Sales % 60.33 -- -48.20
EPS (TTM) % 7.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Dicerna Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.14 -5.88 40 96
13 Week 117.51 103.46 96 71
26 Week 163.70 140.84 96 68
52 Week 152.46 114.45 92 59
YTD 167.36 125.03 93 47
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 71.33%
# of Holders: 49
Total Shares Held: 14,871,514
3 Mo. Net Change: -238,458
# New Positions: 9
# Closed Positions: 9
# Increased Positions: 17
# Reduced Positions: 20
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.